SCHEMBL8418697

SCHEMBL8418697

CC(C)(C)OC(=O)NC1(Cc2ccccc2)CCN2CCC(C(=O)O)N2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIA P62937 2/20 0.45
ACE P12821 4/20 0.42
MME P08473 2/20 0.38
F2 P00734 3/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
F10 P00742 1/20 0.38
PRSS1 P07477 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
NPFFR1 Q9GZQ6 1/20 0.36
NPFFR2 Q9Y5X5 1/20 0.36
MAPK1 P28482 1/20 0.35
KLK5 Q9Y337 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8224968 1.00 PPIA (0.45) PPIAACEMMEF2KMT2A
SCHEMBL8224964 0.90 PPIA (0.42) PPIAACEF2KMT2AL3MBTL1
SCHEMBL8224962 0.90 PPIA (0.42) PPIAACEF2KMT2AL3MBTL1
SCHEMBL8224965 0.90 PPIA (0.42) PPIAACEF2KMT2AL3MBTL1
SCHEMBL8219756 0.78 PPIA (0.42) PPIAACEF2KMT2AL3MBTL1
SCHEMBL27475666 0.75 PPIA (0.52) PPIAF2KMT2AL3MBTL1F10
SCHEMBL8227078 0.74 F2 (0.47) PPIAF2KMT2AL3MBTL1F10
SCHEMBL8225058 0.74 F2 (0.47) PPIAF2KMT2AL3MBTL1F10
SCHEMBL8087931 0.74 PPIA (0.51) PPIAF2KMT2AL3MBTL1F10
SCHEMBL1728442 0.73 PPIA (0.39) PPIAACEKMT2AL3MBTL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511039-B2 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins MYRIAD GENETICS, INC. (US) 2009-03-31 US disclosed
US-20060276408-A1 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins MYRIAD GENETICS, INCORPORATED (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276408-A1 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins SERPINB1, SERPINE1, SERPINA2 PPIA 732/4885ACE 332/4885MME 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.